UnitedHealth Group Incorporated
NYSE:UNH · New York Stock Exchange
+$3.69 today
Vol 11.68M · Avg 8.23M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NYSE:UNH · Revenue to Net Income
Key Ratios
Analysis
$449.7B of revenue converted into $12.0B of net income for the selected period. Gross margin is 18.8% and net margin is 2.7%, showing how much revenue survives after costs and taxes. EPS is $13.24, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $447.6B +11.8% | $400.3B +7.7% | $371.6B +14.6% | $324.2B +12.7% | $287.6B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $364.6B +17.3% | $310.9B +10.8% | $280.7B +14.8% | $244.5B +12.2% | $217.9B | $725.6M | $804.0M | $882.4M |
| Gross Profit | $82.9B -7.3% | $89.4B -1.7% | $91.0B +14.2% | $79.6B +14.3% | $69.7B | $8.9B | $7.6B | $6.2B |
| Gross Margin | 18.5% -3.8pp | 22.3% -2.1pp | 24.5% -0.1pp | 24.6% +0.3pp | 24.2% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 | $0 | $0 | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $0 | $0 | $0 | $0 | $0 | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $64.0B +12.0% | $57.1B -2.5% | $58.6B +14.5% | $51.2B +12.0% | $45.7B | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $4.4B +6.4% | $4.1B +3.2% | $4.0B +16.8% | $3.4B +9.6% | $3.1B | $374.2M | $1.2B | $631.8M |
| EBITDA | $23.1B -17.9% | $28.1B -22.7% | $36.3B +14.1% | $31.8B +17.6% | $27.1B | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | 5.2% -1.9pp | 7.0% -2.8pp | 9.8% -0.0pp | 9.8% +0.4pp | 9.4% | 5.6% | 46.3% | 42.0% |
| Operating Income | $19.0B -41.3% | $32.3B -0.2% | $32.4B +13.8% | $28.4B +18.6% | $24.0B | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 4.2% -3.8pp | 8.1% -0.6pp | 8.7% -0.1pp | 8.8% +0.4pp | 8.3% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $4.0B +2.5% | $3.9B +20.3% | $3.2B +55.2% | $2.1B +26.0% | $1.7B | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$4.3B +65.1% | -$12.2B -276.3% | -$3.2B -55.2% | -$2.1B -26.0% | -$1.7B | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | $14.7B -26.8% | $20.1B -31.1% | $29.1B +10.5% | $26.3B +18.1% | $22.3B | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | 3.3% -1.7pp | 5.0% -2.8pp | 7.8% -0.3pp | 8.1% +0.4pp | 7.8% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $1.9B -60.9% | $4.8B -19.1% | $6.0B +4.6% | $5.7B +24.6% | $4.6B | $1.3B | -$1.6B | $745.2M |
| Net Income | $12.1B -16.3% | $14.4B -35.6% | $22.4B +11.2% | $20.1B +16.4% | $17.3B | $4.9B | $4.8B | $4.7B |
| Net Margin | 2.7% -0.9pp | 3.6% -2.4pp | 6.0% -0.2pp | 6.2% +0.2pp | 6.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | $13 -15.4% | $16 -35.2% | $24 +12.0% | $22 +17.5% | $18 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | $13 -14.7% | $16 -35.0% | $24 +12.7% | $21 +17.1% | $18 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $910.0M -2.0% | $929.0M +0.1% | $928.0M -0.6% | $934.0M -1.0% | $943.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $910.0M -2.0% | $929.0M -1.0% | $938.0M -1.3% | $950.0M -0.6% | $956.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Merck & Co., Inc.
NYSE:MRK
$282.04B
Novartis AG
NYSE:NVS
$281.58B
AstraZeneca PLC
NYSE:AZN
$271.29B
Novo Nordisk A/S
NYSE:NVO
$191.37B
Thermo Fisher Scientific Inc.
NYSE:TMO
$173.12B
Abbott Laboratories
NYSE:ABT
$153.33B
CVS Health Corporation
NYSE:CVS
$125.86B
Elevance Health Inc.
NYSE:ELV
$84.44B
Cigna Corporation
NYSE:CI
$74.48B
Humana Inc.
NYSE:HUM
$43.87B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does UNH generate?
UnitedHealth Group Incorporated (UNH) reported $447.57B of revenue in fiscal 2025.
Is UNH profitable?
UnitedHealth Group Incorporated (UNH) reported $12.06B of net income, with a net margin of 2.7%.
Explore More
Continue the stock analysis
Jump to another research area for this company.